Glycoprotein 210 (gp210) is a pivotal transmembrane protein located in the nuclear pore complex, serving as one of the major components that contribute to the structure and function of the nuclear envelope. It plays a crucial role in the regulation of nucleocytoplasmic transport, acting as a gatekeeper for the movement of molecules between the nucleus and the cytoplasm. gp210 is specifically involved in the anchoring of the nuclear pore complex to the nuclear envelope, facilitating the selective transport of RNA and proteins essential for cellular function and genomic integrity. Its role is fundamental in maintaining the cellular homeostasis and the proper execution of cellular processes such as gene expression, DNA replication, and cell cycle progression. The proper function of gp210 is vital for the cell, as it ensures that the transport of materials necessary for these processes is efficiently managed and regulated.
The activation of gp210 involves a complex interplay of cellular signals and modifications that enhance its function in nucleocytoplasmic transport. This can include post-translational modifications such as phosphorylation, which may alter the conformation of gp210 to increase its affinity for transport factors or other components of the nuclear pore complex. Additionally, the lipid environment of the nuclear envelope can modulate gp210 activity, where changes in lipid composition or dynamics can affect gp210's function in anchoring the nuclear pore complex. The activation of gp210 could also be influenced by the cellular energy state, where ATP levels and the activity of ATPases involved in the transport process can modulate the efficiency of gp210-mediated transport. Moreover, interactions with regulatory proteins that are part of the nucleocytoplasmic transport machinery can serve as another mechanism of activation, where binding to these proteins could enhance gp210's role in the transport process. Understanding the mechanisms behind gp210 activation is crucial for deciphering the regulation of nucleocytoplasmic transport and its impact on cellular physiology and the maintenance of nuclear integrity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Inhibits nuclear export, potentially leading to increased interactions with nuclear pore proteins like NUP210. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Impairs microtubule dynamics and can influence nuclear import/export that may involve NUP210. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
DNA-damaging agent; nuclear damage can lead to changes in nuclear-cytoplasmic transport, possibly engaging NUP210. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
RNA polymerase II inhibitor, potentially engaging NUP210 due to changes in RNA transport. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, potentially influencing nuclear transport processes that involve NUP210. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
RNA and DNA synthesis inhibitor, can influence nuclear-cytoplasmic dynamics, possibly involving NUP210. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
DNA polymerase inhibitor; may indirectly affect nuclear transport processes involving NUP210. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Impairs actin dynamics and may influence nuclear transport, potentially involving NUP210. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
DNA topoisomerase I inhibitor, might induce cellular scenarios where NUP210 plays a role in transport. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Modulator of certain ion channels but also known to interfere with nuclear transport pathways, potentially affecting NUP210. | ||||||